What is DexCom's EPS (diluted)?

DexCom (DXCM) reported EPS (diluted) of $0.51 in Q1 2026.

How has DexCom's EPS (diluted) changed year-over-year?

DexCom's EPS (diluted) increased by 88.9% year-over-year, from $0.27 to $0.51.

What is the long-term trend for DexCom's EPS (diluted)?

Over 3 years (2022 to 2025), DexCom's EPS (diluted) has grown at a 37.2% compound annual growth rate (CAGR), from $0.81 to $2.09.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

DexCom DXCM EPS (Diluted)

EPS (Diluted) at other companies

Travel + LeisureTNL

$1.22+14.0%

Warrior Met CoalHCC

$1.37+956%

Cabot CorporationCBT

$1.27-24.9%

Main Street CapitalMAIN

$0.93-4.1%

MYR GroupMYRG

$2.99+106%

Dave, Inc.DAVE

$4.02+104%

Other financials

Income statement

See full

Revenue$1.2B+15.0%

Gross profit$750.3M+27.4%

Operating income$255.3M+90.9%

Net income$199.5M+89.3%

Balance sheet

See full

Cash & equivalents$1.1B+23.4%

Total debt$143.0M+2.2%

Total equity$3.0B+30.5%

Total assets$6.6B-1.8%

Cash flow

See full

Operating cash flow$525.6M+186%

CapEx$76.6M-12.0%

Free cash flow$449.0M+364%

Valuation

See full

Market cap$25.99B-17.5%

Enterprise value$25.01B-17.9%

P/E27.9×-27.2×

P/S5.4×-1.9×

Profitability

See full

Gross margin61.5%+2.1pp

Operating margin21.4%+6.2pp

Net margin19.3%+6.4pp

FCF margin29.7%+15.8pp

Returns & leverage

See full

Return on equity35.6%+11.9pp

Debt / equity0×0.0×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by DexCom in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is DexCom's EPS (diluted)?: DexCom (DXCM) reported EPS (diluted) of $0.51 in Q1 2026.
How has DexCom's EPS (diluted) changed year-over-year?: DexCom's EPS (diluted) increased by 88.9% year-over-year, from $0.27 to $0.51.
What is the long-term trend for DexCom's EPS (diluted)?: Over 3 years (2022 to 2025), DexCom's EPS (diluted) has grown at a 37.2% compound annual growth rate (CAGR), from $0.81 to $2.09.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.